Rankings
▼
Calendar
JANX Q4 2021 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
JANX
Janux Therapeutics, Inc.
$852M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$10M
-591.2% margin
Operating Income
-$13M
-834.8% margin
Net Income
-$13M
-830.2% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
+39.4%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$12M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$380M
Total Liabilities
$13M
Stockholders' Equity
$366M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
-$10M
$0
—
Operating Income
-$13M
-$2M
-715.1%
Net Income
-$13M
-$2M
-710.6%
← FY 2021
All Quarters
Q1 2022 →